Sameera Aljohani

2.5k total citations
34 papers, 729 citations indexed

About

Sameera Aljohani is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Sameera Aljohani has authored 34 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Infectious Diseases and 6 papers in Molecular Medicine. Recurrent topics in Sameera Aljohani's work include SARS-CoV-2 and COVID-19 Research (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Influenza Virus Research Studies (4 papers). Sameera Aljohani is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Antibiotic Resistance in Bacteria (6 papers) and Influenza Virus Research Studies (4 papers). Sameera Aljohani collaborates with scholars based in Saudi Arabia, United States and Australia. Sameera Aljohani's co-authors include Hanan H. Balkhy, Hamdan Al‐Jahdali, Yaseen M. Arabi, Salim Baharoon, Ali H. Hajeer, Mohammed Al Balwi, Sami Alsolamy, Giamal Gmati, Khaled O. Alsaad and Saleh Eifan and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Critical Care Medicine.

In The Last Decade

Sameera Aljohani

31 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sameera Aljohani Saudi Arabia 14 346 197 116 78 77 34 729
Abi Manesh India 14 415 1.2× 161 0.8× 106 0.9× 56 0.7× 103 1.3× 55 798
Şiran Keske Türkiye 16 293 0.8× 171 0.9× 119 1.0× 45 0.6× 57 0.7× 51 632
Rania M. El-Lababidi United States 10 172 0.5× 97 0.5× 142 1.2× 57 0.7× 57 0.7× 26 563
Stefanie Kampmeier Germany 15 342 1.0× 141 0.7× 137 1.2× 136 1.7× 24 0.3× 52 757
Ali Pormohammad Iran 16 488 1.4× 131 0.7× 83 0.7× 148 1.9× 77 1.0× 34 1.1k
Sounkalo Dao Mali 13 246 0.7× 106 0.5× 80 0.7× 210 2.7× 44 0.6× 51 781
Muna Almaslamani Qatar 20 690 2.0× 332 1.7× 166 1.4× 86 1.1× 198 2.6× 83 1.1k
Anhua Wu China 15 266 0.8× 199 1.0× 168 1.4× 102 1.3× 27 0.4× 42 688
Chih-Cheng Lai Taiwan 7 820 2.4× 207 1.1× 57 0.5× 100 1.3× 180 2.3× 9 1.2k
Serap Şimşek Yavuz Türkiye 12 344 1.0× 180 0.9× 69 0.6× 75 1.0× 97 1.3× 51 739

Countries citing papers authored by Sameera Aljohani

Since Specialization
Citations

This map shows the geographic impact of Sameera Aljohani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameera Aljohani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameera Aljohani more than expected).

Fields of papers citing papers by Sameera Aljohani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameera Aljohani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameera Aljohani. The network helps show where Sameera Aljohani may publish in the future.

Co-authorship network of co-authors of Sameera Aljohani

This figure shows the co-authorship network connecting the top 25 collaborators of Sameera Aljohani. A scholar is included among the top collaborators of Sameera Aljohani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameera Aljohani. Sameera Aljohani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aljohani, Sameera, et al.. (2025). Brucellosis relapse: Rate, patient characteristics, and clinical outcomes in an endemic region. PLoS neglected tropical diseases. 19(7). e0013270–e0013270.
3.
Alghnam, Suliman, et al.. (2022). Prevalence and Clinical Characterization of Bocavirus Infection in a Specialized Children's Hospital in Saudi Arabia. Cureus. 14(2). e22127–e22127. 13 indexed citations
4.
5.
Aljohani, Sameera, et al.. (2022). Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years. IJID Regions. 4. 152–156. 8 indexed citations
6.
Alghoribi, Majed F., et al.. (2022). In vitro activity of cefiderocol against clinically important carbapenem non-susceptible Gram-negative bacteria from Saudi Arabia. Journal of Global Antimicrobial Resistance. 32. 176–180. 8 indexed citations
7.
Akbar, Abdullah, Ahmad M. Alharbi, Ebrahim Mahmoud, et al.. (2022). Clinical Characteristics and Outcome of Candidemia. Saudi Journal of Medicine and Medical Sciences. 10(2). 125–130. 6 indexed citations
8.
Bosaeed, Mohammad, Ahmad M. Alharbi, Mohammad H. Hussein, et al.. (2021). Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19. BMJ Open. 11(4). e047495–e047495. 5 indexed citations
9.
10.
Mahmoud, Ebrahim, et al.. (2021). Non-SARS Non-MERS Human Coronaviruses: Clinical Characteristics and Outcome. Pathogens. 10(12). 1549–1549. 3 indexed citations
11.
Balwi, Mohammed Al, Anis Khan, Yaseen M. Arabi, et al.. (2020). Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Journal of Infection and Public Health. 13(10). 1544–1550. 14 indexed citations
12.
Alghoribi, Majed F., Michel Doumith, Wolfgang Köster, et al.. (2019). S. Enteritidis and S. Typhimurium Harboring SPI-1 and SPI-2 Are the Predominant Serotypes Associated With Human Salmonellosis in Saudi Arabia. Frontiers in Cellular and Infection Microbiology. 9. 187–187. 19 indexed citations
13.
Varghese, Bright, Mushira Enani, Mohammed Shoukri, et al.. (2019). Burden of non-tuberculous mycobacterial diseases in Saudi Arabian children: The first nationwide experience. Journal of Infection and Public Health. 12(6). 803–808. 7 indexed citations
14.
Aljohani, Sameera, et al.. (2019). CandidaBloodstream Infection: Changing Pattern of Occurrence and Antifungal Susceptibility over 10 Years in a Tertiary Care Saudi Hospital. Canadian Journal of Infectious Diseases and Medical Microbiology. 2019. 1–9. 27 indexed citations
15.
Varghese, Bright, Mushira Enani, Mohammed Shoukri, et al.. (2018). The first Saudi Arabian national inventory study revealed the upcoming challenges of highly diverse non-tuberculous mycobacterial diseases. PLoS neglected tropical diseases. 12(5). e0006515–e0006515. 9 indexed citations
16.
Arabi, Yaseen M., et al.. (2018). Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective observational in Saudi Arabia. Annals of Thoracic Medicine. 13(1). 63–63. 4 indexed citations
17.
Algwizani, Abdullah, et al.. (2018). Experience with ceftazidime–avibactam treatment in a tertiary care center in Saudi Arabia. Journal of Infection and Public Health. 11(6). 793–795. 11 indexed citations
18.
19.
Eifan, Saleh, et al.. (2017). A pandemic risk assessment of middle east respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia. Saudi Journal of Biological Sciences. 24(7). 1631–1638. 22 indexed citations
20.
Majrashi, Majed A., Ali H. Bahkali, Ali Azghani, et al.. (2017). Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities. International Journal of Nanomedicine. Volume 12. 6949–6961. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abi Manesh Breakdown of academic impact, for papers by Şiran Keske Breakdown of academic impact, for papers by Rania M. El-Lababidi Breakdown of academic impact, for papers by Stefanie Kampmeier Breakdown of academic impact, for papers by Ali Pormohammad Breakdown of academic impact, for papers by Sounkalo Dao Breakdown of academic impact, for papers by Muna Almaslamani Breakdown of academic impact, for papers by Anhua Wu Breakdown of academic impact, for papers by Chih-Cheng Lai Breakdown of academic impact, for papers by Serap Şimşek Yavuz
Rankless by CCL
2026